Related content

The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder

By Dording Christina   Sinicropi-Yao Lara   Papakostas George   Matthews John   Nierenberg Andrew   Fava Maurizio   Mischoulon David  

Nordic Journal of Psychiatry, Vol. 63, Iss. 5, 2009-10 ,pp. : 420-425

Informa Healthcare

Access to resources Recommend Favorite

Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects

By Roggenbach J.   Müller-Oerlinghausen B.   Franke L.   Uebelhack R.   Blank S.   Ahrens B.  

Journal of Neural Transmission, Vol. 114, Iss. 4, 2007-04 ,pp. : 479-487

Springer Publishing Company

Access to resources Recommend Favorite

Response to Treatment with Placebo, Medication or Psychotherapy in Severe Non- Psychotic Major Depressive Disorder

By  

Current Psychiatry Reviews, Vol. 6, Iss. 1, 2010-02 ,pp. : 28-45

Bentham Science Publishers

Access to resources Recommend Favorite

Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis

By  

World Psychiatry, Vol. 1723-8617, Iss. 3, 2015-10 ,pp. : 339-347

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis

By  

World Psychiatry, Vol. 14, Iss. 3, 2015-10 ,pp. : 339-347

John Wiley & Sons Inc

Access to resources Recommend Favorite